Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
about
The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory TherapyVitamin D and immunityAmyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's diseaseLL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsSerum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis.Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.Local Sustained Delivery of 25-Hydroxyvitamin D3 for Production of Antimicrobial Peptides.Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.In vivo expression of antimicrobial peptides in atopic dermatitis.Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation.Rhesus macaque θ-defensin RTD-1 inhibits proinflammatory cytokine secretion and gene expression by inhibiting the activation of NF-κB and MAPK pathwaysPromotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.The innate immune function of airway epithelial cells in inflammatory lung diseaseNeutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.ProInflam: a webserver for the prediction of proinflammatory antigenicity of peptides and proteinsBlastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37.LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells.The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE.The immediate protective response to microbial challenge.Lipopolysaccharide: basic biochemistry, intracellular signaling, and physiological impacts in the gut.Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages.Immune defence against Candida fungal infections.Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis.Antibiofilm Peptides: Potential as Broad-Spectrum AgentsP2X7 Receptor Regulates Internalization of Antimicrobial Peptide LL-37 by Human Macrophages That Promotes Intracellular Pathogen Clearance.Activation of vitamin D regulates response of human bronchial epithelial cells to Aspergillus fumigatus in an autocrine fashion.NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils.Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.Insight on the impacts of free amino acids and their metabolites on the immune system from a perspective of inborn errors of amino acid metabolism.Endogenous antimicrobial factors in the treatment of infectious diseases.A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity.Allergen specific immunotherapy enhanced defense against bacteria via TGF-β1-induced CYP27B1 in asthma.The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice.Body composition does not affect serum levels of cathelicidin LL-37 in elderly women with unipolar depression.Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.Fungicidal potency and mechanisms of θ-defensins against multi-drug resistant Candida species.Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors.Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
P2860
Q28077916-18635277-1E16-4AEE-897F-65D995FA6B86Q28087758-9C5298B8-E361-43AD-A0EF-2789C23AE271Q33894236-E674AC0C-8E57-42B9-8D9F-2D23705F7D77Q34058299-579FC821-85E4-45C0-8E1E-9152A1DC92CBQ34114368-E3948366-45C5-414C-B0E6-E6590BEE533BQ35060808-402249EA-9932-4DFA-9A98-C5E0638A2679Q35577770-4DFE8845-34C7-4126-AE90-3D7DD43108C7Q35609334-2D7E7DBF-EBBA-4D85-888D-80B24BD79C38Q35744702-D7AA7B0B-C4E7-4AB7-B5E9-BD3953839E19Q35947473-70FD5015-C5D2-4826-B5B4-944790DCCAAEQ36322336-2F2D5CED-DCEB-4C52-A2BE-9BCFDB5581A6Q36322611-BC1F9C04-E808-44AD-AF14-50A90CD7A55AQ36481368-D480E1A7-0C5B-4807-83BB-0135D14C21F9Q36693228-CEFF4953-ABCB-4A2C-8895-41F270B2D87FQ37006535-3ECDE500-626A-49F5-94F5-7EFAE7ADC2C5Q37129880-7FD5E003-79BF-4518-A3A9-3C7B88DEF8FFQ37547116-E5A17181-C0CD-4268-9B3B-03952C6B7C6EQ38219327-45E05E4A-043D-4F7B-8106-8B2FC073DE1FQ38223284-A1C7C370-66D1-4603-9AE2-8DCC1E0C7A9BQ38263175-C062A32F-01FF-405E-8131-CEB3C289D4F3Q38301981-D2B651E7-58BB-40B7-871D-ECDC6EF23E38Q38590007-3025EF77-370C-46B6-BD73-EF1D2F936FB1Q38607528-0C22E5DD-BF11-47FE-8A95-6BA9EBBDFB67Q38805599-4C8D5F7F-2C81-4E0F-AA4B-084EB0342FE6Q38859591-7A4E645E-8DD4-42A8-86E9-5181A14C87E9Q38876832-92908864-CCD7-41F1-8635-C457E012D840Q38998709-1BDE0A75-53FC-4F49-8D96-A7E29DFFB9CBQ39133115-952EF274-D5CA-4E5D-9D45-F2A2DE41FC14Q39261875-A800633B-1E2D-4A42-8D75-F1D3AEAB491DQ39268238-14CF21B0-6121-472F-9F2B-D771D41A0475Q40368781-67581802-B6AD-4199-B24D-BB938A22C26CQ41879955-A37B913C-20F5-4017-A04D-6D38FF37D9E8Q41991209-A4C10AD1-B46A-40B1-A327-014E032DCC73Q46485465-3542D677-1DD3-4AC1-BEBB-CD5E37E04F19Q47429893-6AB51FDD-AB48-4149-B285-48657A292F4BQ47755035-DAE23A15-0CBB-41BE-BD23-0A4AADD230F8Q52448914-0C524657-03E2-4018-8A1A-5E6C5CC8D233Q52611998-F2C31F4D-1F00-4CB2-A837-49CADD139972Q52673160-9CF6E5BE-5029-48F2-A55C-D8D5AE2AE0D1Q52691175-17940983-920E-40BE-BA16-15A978F8D188
P2860
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
@en
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.
@nl
type
label
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
@en
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.
@nl
prefLabel
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
@en
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.
@nl
P2860
P356
P1476
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease
@en
P2093
Mariana J Kaplan
P2860
P304
P356
10.4049/JIMMUNOL.1302005
P407
P577
2013-11-01T00:00:00Z